PACKAGE LEAFLET: INFORMATION FOR THE USER. BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE

Similar documents
Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

PACKAGE LEAFLET. Page 1 of 6

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Motens 2 mg and 4 mg Tablets lacidipine

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

1. What Betahistine dihydrochloride tablets is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

Maxilief Effervescent Tablets

Sibelium 5 mg Tablets flunarizine

What is in this leaflet

Package Leaflet: Information for the user. Methocarbamol 750mg Film-Coated Tablets

Package leaflet: Information for the user. Tetrabenazine 25 mg tablets. tetrabenazine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Naltrexone 50 mg film-coated tablets (Naltrexone hydrochloride)

Package leaflet: Information for the user

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

Pravat 40 mg tablets. Pravastatin sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Package Leaflet: Information for the User Zofran tablets 4 mg and 8 mg ondansetron (as hydrochloride dihydrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets. Alfuzosin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. NEFOXEF 120 MG FILM-COATED TABLETS NEFOXEF 180 MG FILM-COATED TABLETS Fexofenadine hydrochloride

Package leaflet: Information for the patient. Selincro 18 mg film-coated tablets nalmefene

Package leaflet: Information for the user. Co-Codamol 30mg/500mg Capsules (Codeine Phosphate Hemihydrate and Paracetamol)

Imodium 1 mg/5 ml oral solution

2 What you need to know before you take Naramig

Package leaflet: Information for the user. Compound Macrogol Oral Powder Sugar Free

Package Leaflet: INFORMATION FOR THE USER. PARACODIN 10 mg/g oral drops, solution (dihydrocodeine hydrorhodanide)

Package leaflet: Information for the user

1. What Solpadol is and what it is used for

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package leaflet: Information for the user. Tianeptine 12.5 mg Film Coated Tablets (Tianeptine Sodium)

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

Package leaflet: Information for the patient. ROBAXIN mg Film-coated tablets for oral use Methocarbamol. 100 Tablets

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package leaflet: Information for the user. Ursodeoxycholic Acid Tablets 150mg (Ursodeoxycholic acid)

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

Benylin Children's Coughs & Colds 5mg/0.625mg per 5ml Syrup dextromethorphan, triprolidine

Package Leaflet: Information for the User. Kemadrin tablets 5 mg procyclidine hydrochloride

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)

Package leaflet: Information for the patient. Forxiga 5 mg film-coated tablets Forxiga 10 mg film-coated tablets dapagliflozin

TREANA 5mg and 10mg Film-coated Tablets

Package leaflet: Information for the user NON DROWSY SUDAFED. DECONGESTANT 60 mg FILM-COATED TABLETS Pseudoephedrine hydrochloride

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution

PACKAGE LEAFLET: INFORMATION FOR THE USER ANQUIL 0.25mg TABLETS Benperidol

Package leaflet: Information for the user. Ezetimibe STADA 10 mg, tabletten. Ezetimibe

Ventolin Accuhaler 200 micrograms salbutamol sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Package leaflet: Information for the user

Ventolin Injection 500 micrograms/ml salbutamol sulfate

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

PROSCAR 5mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT PROSCAR IS AND WHAT IS IT USED FOR

Package leaflet: Information for the user. Lorastad 10 mg Tablets loratadine

IBS Relief 135 mg Tablets Mebeverine Hydrochloride

Package leaflet: Information for the user. Zomig 2.5 mg tablets zolmitriptan

Package leaflet: Information for the patient

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine

PATIENT INFORMATION LEAFLET TEXAMER

Package leaflet: Information for the user. Finasterid Actavis 5 mg film coated tablets. Finasteride

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

Flecainide BNM. Please read this leaflet carefully before you start taking Flecainide BNM.

Package leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium)

PACKAGE LEAFLET: INFORMATION FOR THE USER PROPECIA 1 mg film-coated Tablets (finasteride)

PACKAGE LEAFLET. Page 1 of 8

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tipuric 100 & 300 mg Tablets Allopurinol

Package Leaflet: Information for the User

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Read all of this leaflet carefully before you start taking this medicine.

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil

Some general information on hepatitis A infection is given at the end of this leaflet.

Package leaflet: Information for the patient

Otezla (apremilast) film coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

NALOREX 50mg Film Coated Tablets (Naltrexone Hydrochloride)

PYRIDOSTIGMINE LIME TM 60MG TABLETS Pyridostigmine bromide

PATIENT INFORMATION LEAFLET FOR TEXA 10 mg TABLETS AND TEXA SYRUP PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM:

PACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride)

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER BritLofex Tablets 0.2mg LOFEXIDINE HYDROCHLORIDE Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may need to read it again. - This leaflet does not contain all the information about your medicine. - If you have any further questions, ask your doctor or community drugs worker. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or community drugs worker. In this leaflet: 1. What BritLofex is and what it is used for 2. Before you take BritLofex 3. How to take BritLofex 4. Possible side effects 5. How to store BritLofex 6. Further information 1. WHAT BRITLOFEX IS AND WHAT IT IS USED FOR BritLofex belongs to a group of medicines called alpha 2 adrenergic agonists and is an imidazoline derivative. The tablets are taken to relieve the symptoms such as chills, sweating, stomach cramps, muscle pain and runny nose which you experience when you stop taking an opioid (e.g. methadone, heroin, dihydrocodeine etc.) BritLofex will not stop you from craving opioids. 2. BEFORE YOU TAKE BRITLOFEX Do not take BritLofex if: - you are allergic to Lofexidine or to other imidazoline derivatives or to any ingredients of BritLofex (See Section 6 for a full list of ingredients). Take special care with BritLofex Before taking BritLofex tablets, tell your doctor or community drugs worker if: you are, or think you might be, pregnant; you are breast-feeding; you have a heart condition (e.g. angina), or have had a recent heart attack; you have a low pulse rate; you have low blood pressure; you have a low potassium level; you have kidney problems; you suffer from depression; you are taking tablets for depression; you are taking barbiturates or other sedatives; you have ever had a stroke; you have been diagnosed with the heart condition QT prolongation or have a family history of QT problems; Page 1 of 5

you are elderly (aged 65 and over) and are receiving treatment for high blood pressure. Taking other medicines Certain medicines need to be used with caution whilst taking BritLofex. Please consult your doctor or community drugs worker if you are currently taking, or intend to take any other medication whilst taking BritLofex. BritLofex may increase the effects of alcohol, medicines called barbiturates and other drugs that make you sleepy. BritLofex may increase the effects of medicines used to lower high blood pressure and it could make your blood pressure drop too low. Taking medicines known as tricyclic antidepressants may reduce the effects of BritLofex. Other medicines known to change heart rhythm or alter the balance of electrolytes (e.g. sodium, potassium etc) should be avoided. Taking these drugs with BritLofex may increase the risk of QT prolongation. Taking BritLofex with food and drink It is recommended that you do not drink alcohol or take opioids while you are undergoing detoxification with BritLofex. Pregnancy and breast-feeding Ask your doctor or community drugs worker for advice before taking any medicine. Driving and using machines BritLofex tablets may make you feel light-headed or drowsy. You must not drive or operate machinery if you feel light-headed or drowsy. Important information about some of the ingredients of BritLofex - BritLofex tablets contain sunset yellow (E110) which can cause allergic reactions. If you have ever been told that you are allergic to sunset yellow (E110), contact your doctor before taking this medicine. - BritLofex tablets contain lactose (a kind of sugar). If you have ever been told that you have intolerance to some sugars, contact your doctor before taking this medicine. WARNING! If you are unable to continue with your detoxification programme you should contact your doctor or community drugs worker as soon as possible. 3. HOW TO TAKE BRITLOFEX Read the label on your medicine before you start to take it. Your doctor or community drugs worker will tell you when and how often to take the tablets. Page 2 of 5

Your doctor or community drugs worker will explain how to stop using opioids and the course of treatment to follow during the withdrawal stages. Please follow these instructions as closely as possible: - On the first day the usual dose is 4 tablets. - After that, the dose can then be increased gradually, depending on the severity of your symptoms, but any increase must not be more than 4 tablets a day. - The maximum daily dose is 12 tablets. - You must not take more than 4 tablets at a time. Sometimes the dosage may differ from this. For example, you may be prescribed a higher starting dose. Your doctor or community drugs worker will tell you the number of tablets you need to take each day. BritLofex is usually taken for 7-10 days. Sometimes, however, it may be taken for a longer or shorter time. Your doctor or community drugs worker will tell you how long to take the tablets for. When the withdrawal symptoms are less severe the daily dose of BritLofex can be reduced, gradually. You should never stop taking these tablets suddenly. Swallow your tablets whole with a drink of water. BritLofex tablets are not suitable for children (aged under18). If you take more BritLofex than you should If you take more tablets than you have been told to, tell your doctor or community drugs worker or contact your nearest hospital emergency department immediately. Always take the tablets as your doctor or community worker has told you to. If you forget to take BritLofex If you forget to take a dose, take another as soon as you remember, but do not take more than 4 tablets at a time. How to stop taking BritLofex Never stop your tablets suddenly because your blood pressure might rise if you do so. The dose should be lowered gradually, over several days. Your doctor or community drugs worker will tell you how to do this. After finishing your tablets After completing the course of BritLofex tablets you should be detoxified from opioids and no longer have the withdrawal symptoms. However, if you are still having withdrawal symptoms after you have finished your tablets, tell your doctor or community drugs worker. Your doctor or community drugs worker will offer advice on how to remain opioid free. 4. POSSIBLE SIDE EFFECTS If you experience an allergic reaction stop taking BritLofex and contact a doctor or your nearest hospital emergency department immediately. The signs of an allergic reaction may include: Page 3 of 5

Rash Breathing difficulties Swelling of the face, lips, throat or tongue Like all medicines, BritLofex can cause side effects, although not everybody gets them. BritLofex tablets may sometimes cause the following: Very common side effects (more than 1 user in 10): light-headedness or dizziness feeling sleepy or falling asleep drop in blood pressure slow heart beat dry mouth or throat dry nose Side effects with unknown frequency: an allergic reaction which may include: o Rash o Breathing difficulties o Swelling of the face, lips, throat or tongue Changes in heart rhythm If you think you have any of these or any other side effects not mentioned in the leaflet, contact your doctor or community drugs worker. When you stop taking opioids, the withdrawal symptoms can make you feel unwell. If you think, however, that it is the BritLofex tablets which are making you feel unwell, tell your doctor or community drugs worker. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed below. By reporting side effects you can help provide more information on the safety of this medicine. Yellow Card Scheme Website: www.yellowcard.mhra.gov.uk 5. HOW TO STORE BRITLOFEX Always keep Britlofex and all other medicines out of the reach and sight of children. Do not use BritLofex after the expiry date which is printed on the pack. The expiry date refers to the last day of that month. Store your tablets below 25ºC. Store them in the original package. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the safety of others and the environment. Page 4 of 5

Remember: this medicine is for you. Do not give it to others, even if they have the same symptoms as you. You may want to read this leaflet again. Do not throw it away until you have finished your medicine. 6. FURTHER INFORMATION If you are not already doing so, you may wish to contact your local drug addiction service. They will be able to offer you advice and support on how to come off drugs. You will find their address in the 'Yellow Pages' telephone directory under 'Counselling & Advice'. What BritLofex contains The active ingredient of each peach coloured BritLofex tablet is Lofexidine hydrochloride. Each tablet contains 0.2mg of Lofexidine hydrochloride. The other ingredients are: lactose, citric acid, povidone, microcrystalline cellulose, calcium stearate, sodium lauryl sulphate, Opadry OY-S-9480 Brown (which contains sunset yellow - E110). These are included to help make the tablets. What BritLofex looks like and contents of the pack BritLofex tablets are round and peach-coloured. They are supplied in packs of 60 tablets. Marketing Authorisation Holder Britannia Pharmaceuticals Ltd 200 Longwater Avenue Green Park Reading Berkshire RG2 6GP United Kingdom Manufacturers Suir Pharma Ireland Waterford Road, Clonmel, Co Tipperary, Ireland Britannia Pharmaceuticals Ltd., 200 Longwater Avenue, Green Park, Reading, Berkshire, RG2 6GP, UK Distributed by: Britannia Pharmaceuticals Ltd., 200 Longwater Avenue, Green Park, Reading, Berkshire, RG2 6GP, UK This leaflet was last revised in April 2015 Page 5 of 5